Category: Dangerous Drugs


Irbesartan Lawsuit

Side effects of the blood pressure medication Irbesartan may include cancer, as the drug was recalled in January 2019 for contamination with a carcinogen.

Rockstar Energy Drink

Energy Drinks Linked to Kidney Disease Risk: Study

A new study from Johns Hopkins Bloomberg School of Public Health has identified yet another link between the consumption of sugar-laden energy drinks and an increased risk for kidney disease.


AbbVie to Pay $3M AndroGel Settlement

AbbVie Inc., maker of the best-selling testosterone supplement Androgel, has been ordered to pay $3 million over a lawsuit filed by an Oregon man who claimed that the product caused him to have a heart attack.

Medicine & Money

Opioid Deaths Among Children Triple in 20 years: JAMA Study

Synthetic opioid medications have produced an increased mortality rate of 2,925% in children and teens since 1999, according to a new study from the Journal of the American Medical Association (JAMA).


Fluoroquinolone Antibiotics May Cause Fatal Heart Damage: FDA Warning

Prescription medications commonly used to treat upper respiratory infection, urinary tract infections (UTIs) can cause painful and sometimes life-threatening damage to the body’s main artery, the U.S. Food & Drug Administration (FDA) is warning.

Synthetic Cannabinoid

Synthetic Cannabinoids Linked to Severe Bleeding: CDC Warning

More than 200 cases of severe and unexplained bleeding from synthetic cannabinoids suspected of being laced with rat poison have been reported to the U.S. Centers for Disease Control and Prevention (CDC), the agency announced on May 25, 2018.

doctor brain mri

Campath Lawsuit

The FDA recently issued an urgent Drug Safety Alert indicating that alemtuzumab, the active ingredient in leukemia treatment Campath, had been linked to an increased risk for stroke and blood vessel wall tears (arterial dissection).


Lemtrada Class Action

Our class action lawyers are investigating potential lawsuits for people who suffered major injuries after taking the multiple sclerosis drug Lemtrada (generic: alemtuzumab), which has recently been linked to an increased risk for stroke, blood vessel wall tears (arterial dissection),...


Lemtrada Lawsuit

The U.S. Food & Drug Administration (FDA) on November 29, 2018, issued an urgent Drug Safety Communication indicating that the multiple sclerosis (MS) treatment Lemtrada (generic: alemtuzumab) will henceforth carry a boxed warning -- the strongest warning allowed by U.S....


LGD-3303 Class Action

LGD-3303 is an unapproved SARM used by many as a ‘legal steroid’ who mistakenly believe it to be free of side effects, when in reality it may increase your risk of liver failure, heart attack and blood clots.